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Abstract
Caughie, Cali, Ph.D., Spring 2021

Clinical Psychology

Biobehavioral Predictors of Executive Function Decline in Mid- and Late Life Adults
Chairperson: Stuart Hall, Ph.D.
Using data from the Midlife in the United States (MIDUS) Longitudinal Study of Health
and Well-Being, this study examined high frequency heart rate variability as a longitudinal
predictor of cognitive change in key executive function domains: inhibition, shifting, and
updating. This study further explored the interactions between HF HRV and important health
factors (inflammation, stress, sleep, and mood and anxiety) in predicting executive function
decline.
The results of this investigation demonstrated that while high frequency heart rate
variability and inhibition decline were correlated, HF HRV was not a significant predictor of
decline in any executive function. However, results did show an interaction effect between HF
HRV and depression in predicting inhibition and shifting declines in mid-life adults. Further,
main effects of sleep quality and anxiety on inhibition and shifting declines were identified.
Implications of these findings as well as limitations and future research directions are discussed.

Keywords: cognitive performance, executive function, heart rate variability, Midlife in the
United States, aging

iii

Running head: BIOBEHAVIORAL PREDICTORS OF EXECUTIVE FUNCTION DECLINE
Dedication
This work is dedicated to the many research participants who generously shared
their time in support of science. It is further dedicated to the extensive number of researchers
integral in conducting the Mid-life in the Unites States Study on Health and Well-being. It took a
national community to make this study feasible, and I thank each person who worked to collect
and compile study data.

Acknowledgements
I also wish to acknowledge the many individuals integral to the completion of this
dissertation. I would firstly like to thank my advisor and dissertation chair, Dr. Stuart Hall, for
his faithful support of my spirited scientific undertakings and his genuine investment in his
students as people and professionals. I would also like to thank my dissertation co-chair, Dr.
John Quindry, for his openness and enthusiasm towards scientific collaboration, helping me to
integrate research across disciplines. Additional thanks go to Nicholas Coomb and Daniel Denis
for their statistical guidance throughout this research process. Thank you as well to my additional
Dissertation Committee members Allen Szalda-Petree, Nathan Insel, and Rachel Severson. You
are all people I deeply admire and respect—I so appreciate your support in this journey.
Further, I would like to thank my amazing partner and my incredible network of friends
and family. I am privileged to have an abundance of love in my life. Thank you as well to our
public lands. It is in these places that I find the energy and balance necessary for my academic
pursuits.

iv

Running head: BIOBEHAVIORAL PREDICTORS OF EXECUTIVE FUNCTION DECLINE
Table of Contents
Abstract…………………………………………………………………………………...………iii
Dedication and Acknowledgements………………………………………………………….......iv
Table of Contents………………………………………………………………………………….v
Background………………………………………………………………………………………..1
Theoretical Underpinnings………………………………………………………………………...2
Heart Rate Variability (HRV)……………………………………………………………………..4
Neurovisceral Integration…………………………………….………………………………...…7
Heart Rate Variability and Executive Function………………………………………………….10
Executive Function and Aging…………………………………………………………………...11
Executive Functions (EF)………………………………………………………...……………...12
Hypotheses……………………………………………………………………………………….16
Method…………………………………………………………………………………………...17
Measures…………………………………………………………………………………18
Procedure……………………………….………………………………………………..22
Results…………….………………………………………………………………………….......24
Correlations……………………………………….……………………………...………26
Predictors……………………………………………………………………………...…32
Moderators………………………… ……………………………………………………36
Discussion……………..…………………………………………………………………………38
Limitations……………………………………………………………………………….44
Conclusions………………………………………………………………………………………47
References………………………………………………………………………………………..49

v

Running head: BIOBEHAVIORAL PREDICTORS OF EXECUTIVE FUNCTION DECLINE
Background
The Brain-Body Connection
The question of the relationship between brain and body has a long and varied history;
yet, what is clearly demonstrated across scientific disciplines is that the brain and the body are
intimately connected. Oxygen and glucose are exchanged between our cardiovascular system and
our cerebral vasculature, our gut communicates through neurotransmitters to our brains, and
certain central nervous system nerves innervate our bodily organs (Roy & Sherrington, 1890;
Breit, Kuperberg, Rogler, & Hasler, 2018). What’s more, when we exercise the body we
stimulate the mind, and when we engage our minds we can alter our physiology (Webb &
Acevedo, 2018). Even in an act as simple as breathing, an intricate dance between mind and
body is occurring.
Given that the brain and body coordinate actions within a changing environment, an
important aspect of their interrelated function is adaptability. Indeed, in order to survive, humans
must actively change and adapt as we navigate diverse environments. Importantly, we need to be
able to think, feel, and act flexibly. Whether solving complex cognitive problems or adjusting
our emotional style to different contexts, flexibility in both brain and body functions has been
key in evolutionary human success (Riganello, Garbarino, & Sannita, 2012).
Nervous System Flexibility
Indeed, flexibility in both the central and autonomic nervous system increases humans'
ability to adapt and regulate cognitive, affective, physiological, and behavioral responses to
environmental cues. Further, research supports that flexibility in these systems is related to
wellbeing, cognition, and affective health (Mulcahy, Larsson, Garfinkel, & Critchley, 2019). In
-1-
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contrast, when cognitive and/or visceral systems become rigid, we often see decreased cognitive,
physical, and emotional functional ability and an increase in mental and physical disorder and
disease. Of course, this is a balance—too much flexibility or too little rigidity can be nonbeneficial as well.
We know this from research as well as from practical knowledge—when our muscles are
too rigid our movement is limited; when we are too restricted in emotion we fail to engage
adaptively across situations; and when our thinking is not flexible enough we get cognitively
stuck. While this may seem like common sense, research is limited in understanding how
physical, emotional, and cognitive systems interact. However, it is suspected that positive and
negative feedback cycles between these systems may contribute to health versus disease (Seeman
& Gruneswald, 2006). Parsing apart the interactions between these dynamic systems and their
relationship to health outcomes is a vast and imperative field of study.
Theoretical Underpinnings
Systems Theory
The notion of such dynamical interaction is integral to systems theory, which posits that
effective adaptation to changing environments requires a flexible relationship among the
dynamic parts of a living system (Nesselroade, 1990; Weiss, 1969). In this view, the more
variable the parts of a system are, the more effective the system works overall. This is also in line
with the concept of allostasis, wherein organisms maintain homeostasis through physiological
and behavioral change. Extensive research supports this and shows low variability in system
functions is related to disorder and disease while higher variability is related to health and
adaptability (Seeman & Grunewald, 2006). Indeed, pathological states are commonly related to
-2-
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extreme predictability and low variability in physiologic markers such as heart rate (Goldberger,
1992; Goldberger, 1996).
Researchers suggest these associations are related to homeodynamics. In this view,
system functions are dependent on multiple inputs at any given moment (Apple et. al., 1989).
Thus, disruptions of feedback loops within lower-order system parts can contribute to
increasingly higher-order system disruptions, at times resulting in pathology. As examples,
increases in physiological rigidity are shown to be related to shifts towards rigidity in perception,
behavior, and cognition resulting in the psychopathology of both Generalized Anxiety Disorder
and Panic Disorder (Friedman et al., 1993, Friedman et al., 2000, Friedman and Thayer,
1998a, Thayer et al., 1996, Thayer et al., 2000).
Polyvagal Theory
In contrast to the systemic rigidity found in pathology, when mammals are functioning
healthily, there is a flexible tradeoff between system levels. This is important given that we are
social creatures living in a constantly variable environment. We need to be able to assess when
we are faced with environments of threat versus safety and adapt effectively at physiological,
affective, and cognitive levels.
Polyvagal theory supports that these flexible changes are carried out by the vagus nerve,
which signals between visceral and neural systems as part of the parasympathetic branch of the
autonomic nervous system (Porges, 1995). The autonomic nervous system is broadly made up of
the parasympathetic and sympathetic nervous systems. In sympathetic nervous system (SNS)
activation, epinephrine and norepinephrine act on beta-adrenergic receptors leading to the release
of hormones throughout the bloodstream. These hormones are then able to act on multiple organ

-3-
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systems to ready an organism to fight, flee, or freeze in order to mitigate threat (e.g., heart rate
increases, vasculature constricts, sweating increases, etc.). In contrast, during parasympathetic
nervous system (PNS) activation, the vagus nerve releases acetylcholine which acts on
muscarinic and nicotinic receptors, causing specific intracellular effects which result in a
multisystem response preparing an organism to “rest and digest” in times of safety (e.g., blood
vessel dilation, decreased heart rate, etc.). Interestingly, the cholinergic effects of the PNS also
function to degrade norepinephrine and attenuate the response of adrenergic receptors to
sympathetically activated neurotransmitters (McCorry, 2007). In this way, sympathetic activation
is dependent on disinhibition of the parasympathetic response. In normally functioning
organisms, the parasympathetic response is the greatest determinant of autonomic function and
many research studies therefore focus on PNS activity as a marker of the autonomic stress
response.
Across numerous disciplines, specific assessment of PNS function has relied on the
measurement of vagal modulation, which has been supported as an important indicator of the
physiological adaptation to stress. This is unsurprising given the impact of the vagus nerve in the
PNS response (Porges, 2011). Yet, how do we measure this significant organismal response in
humans? Years of research have shown that a valid marker of vagal modulation is high
frequency heart rate variability (HF HRV), a measure of variability in beat-to-beat heart rate
intervals (Billman, Huikuri, Sacha, & Trimmel, 2015).
Heart Rate Variability
Overall, heart rate variability is a broad term, encompassing numerous measures. Heart
rate variability began its journey towards becoming a well-established quantitative marker of

-4-
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autonomic activity as early as 1965, when Hon and Lee discovered that changes in physiological
rhythms in beat-to-beat heart rate intervals preceded changes in heart rate in cases of fetal
distress. Later researchers found that HRV was a strong, independent predictor of mortality
following myocardial infarction, and in the Framingham Heart study, reductions in HRV were
able to predict mortality beyond traditional key risk factors (Tsuji et al., 1994). With the
development of measurement technology such as power spectral analysis and ECG recordings,
HRV is now used in numerous fields to assess autonomic function and its relation to diverse
human health factors (Akselrod et. al, 1981; McCraty & Shaffer, 2015).
HRV analyses include the quantification of time domain and frequency domain measures.
Time domain measures revolve around R to R (RR) intervals, a measure of the time between
QRS complexes evidenced on electrocardiogram (ECG) recordings. The QRS complex refers to
Q, R, and S which are specific points in the wave form which represent a heartbeat. RR intervals
measure the time between R wave forms and are also called normal-to-normal (NN) signifying
“normal” heartbeats (Figure 1). Common time domain measures include the square root of
variance of NN (SDNN) and the root mean square of the standard deviation (RMSDD). On the
other hand, frequency domain measures assess how the variance in power distributes as a
function of frequency. Heart rate rhythm is made up of multiple frequency bands which can be
separated out through power spectral analysis. Common frequency domain measures include low
frequency (LF) and high frequency (HF) HRV (Figure 2). LF heart rate variability is measured
between 0.04 and 0.15 hertz and HF heart rate variability is measured between 0.15 and 0.40
hertz (Society of Cardiology Task Force Report, 1996).

-5-
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Figure 1. ECG waveform analysis is used for HRV measurement. RR intervals are the
intervals between R waves within recorded QRS complexes. Figure adapted from Dong
(2016).

Figure 2. Frequency domain measures are used for measuring autonomic cardiac control.
Power spectral analysis identifies high and low frequency waveform activity which can
then be used to determine HF or LF HRV. Figure retrieved from ans-analysis.com.

While heart rate variability can be measured in many ways, it is important to understand
that the high frequency aspect of HRV has the most biological relevance when investigating the
relationship between neural and visceral systems. Particularly, this is because it is directly tied to
parasympathetic nervous system activity and vagal modulation. Indeed, efferent vagal activity is
a main contributor to HF HRV. This is evidenced in studies of electrical vagal stimulation,
muscarinic receptor blockade, and vagotomy (Task Force Report, 1996). HF HRV is an exciting
measure of autonomic function as it taps into vagal nerve function and has been shown to be a
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promising indicator of both psychological and behavioral function, as well as health and disease
(Labord, Mosley, & Thayer, 2017).
Indeed, replicated studies have found that lower HF HRV is associated with affective
disorders such as depression and anxiety (Gorman and Sloan, 2000, Kemp and Quintana, 2013,
Kemp et al., 2012, Kemp et al., 2010) and that higher HF HRV is associated with better emotion
regulation ability (Appelhans and Luecken, 2006, Butler et al., 2006, Ingjaldsson et al., 2003,
Lane, 2008, Melzig et al., 2009, Ruiz-Padial et al., 2003, Thayer and Brosschot, 2005). HF HRV
has also been related to cognitive function, with greater HF HRV correlated to better
performance on cognitive tasks involving memory, attention, and executive function (Hansen et
al., 2009, Hansen et al., 2004, Hansen et al., 2003, Johnsen et al., 2003, Saus et al., 2006, Thayer
et al., 2005). Additionally, HF HRV has been associated with numerous health outcomes
including all-cause mortality, cardiovascular disease, reduced risk for stroke, better glucose
regulation, reduced inflammation, and better function of the hypothalamic-adrenal-pituitary axis
(Brosschot et al., 2007, Liao et al., 2002, Thayer and Fischer, 2009, Thayer and Lane, 2007,
Thayer and Sternberg, 2006).
Neurovisceral Integration (NVI) Theory
So how is it that vagal modulation can exert such widespread effects? A predominant
scientific theory developed by Thayer et. al, (2000) suggests the answer lies in neurovisceral
integration. The neurovisceral integration model was first conceptualized in order to provide a
theoretical basis for the mechanisms by which vagal control relates to cognition, affect, and
physical health.

-7-
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At its core, NVI proposes that vagal modulation is enacted through reciprocally
connected areas of the central autonomic network (CAN) which work to dynamically modulate
self-regulation and organismal adaptation (Thayer & Lane, 2000).
Briefly, the CAN is comprised of the ventromedial prefrontal cortices, the insula, the
anterior cingulate, the central nucleus of the amygdala, the paraventricular and related nuclei of
the hypothalamus, the periaquaductual gray matter, the parabrachial nucleus, the nucleus of the
solitary tract (NTS), the nucleus ambiguous, the ventrolateral medulla, the ventromedial medulla,
and the medullary tegmental field, among others (Thayer et al., 2009; Ellis and Thayer, 2010). Its
primary output is to the sino-atrial (SA) node of the heart via preganglionic sympathetic and
parasympathetic neurons which innervate the stellate ganglia and vagus nerve.
The SA node, also known as the pacemaker of the heart, is supported to control contextspecific cardiac regulation taking into account information from both the body and the external
environment. It is thus a juncture of heart and brain integration. Interestingly, HF HRV is
proximally determined at the SA node, and therefore it is suggested that HF HRV can be
understood as an index of the level of integration between the central and autonomic nervous
system (Shaffer & Venner, 2013).
Research studies have supported the NVI model at these structural and functional levels,
showing that HF heart rate variability is associated with described neural networks and with the
regulation of physiology, affect, and cognition. Indeed, the CAN has been supported to
contribute to flexible, adaptive responses to environmental demands at visceromotor,
neuroendocrine, and behavioral levels (Thayer and Lane, 2000; Thayer et al., 2009; Park et al.,
2013a).

-8-
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In 2017, the NVI model was expanded to incorporate developments in functional
neuroanatomy and computational neuroscience. At a basic level, Smith, Thayer, Khalsa, and
Lane (2017), proposed that a series of hierarchical feedback loops interact to regulate heart and
brain function. This system of feedback loops spans from output in the sinoatrial node of the
heart to prefrontal cortical activity. The series of loops reflects a multi-level neural architecture
in which all levels are influenced by, generate, and/or express vagal control. Each level and their
associated functions are depicted in Figure 3. The purpose of these integrated interactions is
suggested to aid in minimizing prediction errors as we continually adjust and flexibly adapt to
our environment.

Figure 3. Hierarchical levels of neurovisceral integration and their functional and structural
relationships. Figure retrieved from Smith et. al (2017).
-9-
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Heart Rate Variability and Executive Function
This theory is appealing to philosophers and mathematicians as it has properties of a
complex nonlinear dynamic system. But without diving headlong into the joys of chaos theory,
we can use neurovisceral integration theory to examine relationships between system levels and
to predict what factors might modulate these relationships. For instance, we expect the function
of the heart to affect the function of the brain. We also expect that the more flexible autonomic
function is, the more flexibility we will observe in cognitive functions. Using HF HRV and
executive function as measures of these domains, prior research supports these expectations.
Indeed, the majority of published studies investigating the relationship between HF HRV
and executive function have found that heart rate variability and executive function are positively
correlated. Specifically, increased HF HRV is shown to relate to higher executive function in
undergraduates (Bailey, Potter, Lang, & Pisoni, 2015; Alderman, & Olson, 2014; Williams,
Thayer, & Koenig, 2016; Williams, et al., 2019; Colzato, et al., 2018), working age adults
(Stenfors, Hanson, Theorell, & Osika, 2016; Zeki Al Hazzouri, Elfassy, Carnethon, Lloyd-Jones,
& Yaffe, K, 2017), seniors (Albinet, Abou-Dest, André, & Audiffren, 2016; de Oliveira Matos,
Vido, Garcia, Lopes, & Pereira, 2020), panic disorder patients (Hovald et al., 2012), and young
male sailors of the Royal Norwegian Navy (Hansen, Johnsen, & Thayer, 2003; Hansen Johnsen,
Sollers, Stenvik, Thayer, 2004).
That said, other studies have not found a clear relationship between autonomic and
cognitive function. For instance, Britton et al. 2008 did not find any consistent associations
between HF HRV and EF and while Jennings et al, 2015 did find a small number of correlations
between specific executive functions and HF HRV, it did not find those same associations in the
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African American participants. It is possible this reflects the inconsistent use of measures and
covariates between studies.
We would also expect that factors affecting neurovisceral integration would moderate the
relationship between HF HRV and executive function. Indeed, if the effects of HF HRV are
communicated through a series of hierarchical feedback loops embedded in certain organ
systems and neurological networks, we would expect that factors affecting these systems and
networks would affect the relationship between HF HRV and executive function, given that
executive function is the final common pathway in neurovisceral integration.
In particular, inflammation, cortisol, sleep, and mood and anxiety are all shown to affect
components of neurovisceral integration. The vagus nerve controls the inflammatory reflex, a
central component of immune homeostasis (Tracey, 2002). Cortisol is released as part of the
hypothalamic pituitary adrenal axis response during the physiologic stress response (Thayer &
Sternberg, 2006). Further, HF HRV and executive function have been found to be reduced in
those with Major Depressive Disorder and Generalized Anxiety Disorder (Kemp, et. al, 2012),
and insomnia symptoms have been related to decreased cognitive performance on executive
function tasks (Hovland et al., 2013). Yet, while many neuroendocrine, autonomic, and neural
mechanisms contribute to neurovisceral integration components, very little is known regarding
what may moderate the observed relationship between HF HRV and cognitive performance.
Overall, it is clear more research is needed to better understand the relationship between
HF HRV and EF. Moreover, it is important to understand not only if this relationship exists in
additional research samples but also how it is moderated and how it develops over time. This is
especially crucial given the role executive function plays in the lives of aging adults. Increasing
our awareness of the contributing factors to executive function decline, and researching
- 11 -
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potentially modifiable factors for its maintenance, may underscore our society’s ability to live
well into old age.
Executive Function and Aging
Indeed, in the next 15 years, and for the first time in history, the United States population
is projected to have more older adults than children under the age of 18 (Census, 2020). While
living longer underscores significant advancement in health and medicine, research regarding
how to live better in older age is a nascent field of study which requires significant attention.
What we do know is that one important predictor of quality of life in older adults is
cognitive function. More specifically, executive function has emerged as the best cognitive
predictor of the ability to perform instrumental activities of daily living (Mograbi, 2014). This is
highly relevant to the quality of life of American older adults, as the ability to perform these
instrumental activities is what allows individuals to live autonomously and independently
(Chaves, 2015). The fact that executive function is vital for independence is unsurprising when
examining the cognitive abilities it represents.
Executive Functions
Executive function is a broad term which comprises a multitude of skills such as
planning, problem-solving, reasoning, inhibition, task switching, memory updating, performance
monitoring, and cognitive flexibility. Each function involves multiple cognitive processes and a
complex network of brain areas (Phillips & Henry, 2008).
A predominant theory of executive function indicates that executive functions are both
unitary and distinct. Through latent variable analysis, Miyake et al. (2000) indicate measurable
distinct aspects of executive function are inhibition, shifting, and updating in working memory.
- 12 -
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Inhibition is one's capacity to supersede responses that are prepotent in a given situation (i.e., the
ability to stop and reflect before acting on impulse/strong emotion). Shifting is one's cognitive
flexibility to switch between different tasks or mental states (i.e., the ability to adapt thoughts
and behaviors to new, changing, or unexpected events), and updating is the continuous
monitoring and quick addition or deletion of contents within one's working memory (i.e., the
ability to hold in the mind actions and behaviors as they are carried out to ensure everything is
going to plan). Each specific function has a differential influence on cognitive aging, and thus, it
is recommended that executive functions be considered independently in research (Miyake &
Friedman, 2012).
In terms of neuroanatomical correlates, executive functions have often been associated
with the frontal lobes (Stuss, 2011). More particularly, specific executive functions have been
associated with prefrontal regions including the dorsolateral, ventromedial, anterior cingulate,
and orbitofrontal subcortical circuits (Alvarez & Emory, 2006). However, it is suggested that the
frontal lobes, and particularly the prefrontal cortical areas, are necessary though not sufficient for
executive functions. This is because these cortical areas do not operate in isolation as they
receive input from a multitude of other cortical, subcortical, and brainstem sites (Bressler &
Menon, 2010).
High Frequency Heart Rate Variability and Executive Functions
Interestingly, the notion that cognition is the result of dynamic interactions of distributed
brain areas rather than an outcome of isolated neural networks isn’t all that old. In some ways,
the idea that cognition is actually a result of even broader inputs is a natural progression of our
understanding of neuroscience. In recent years, researchers have suggested that we must look
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beyond the brain and to the larger organism-environment system to understand cognition
(Kiverstein & Miller, 2015).
In the case of the prefrontal cortex, the predominant site of executive function, if we
zoom out, we find a number of neural networks. If we zoom out further, we find that many of
these neural networks are regulated by vagal control. Neuroimaging and pharmacological studies
allow us to see this both structurally and functionally. From the prefrontal cortex, to the cingulate
cortex, to the insula, to the amygdala, to the midbrain, to the brainstem, to cardiac ganglia, to the
heart—systems are dynamically related (Mulcahy, Larsson, Garfinkel, & Critchley, 2019).
What’s more, healthy connectivity in these regions has been related to better, more flexible
control of physiological resources. In contrast, atypical connectivity has been related to a
decreased ability to recruit and utilize appropriate physiological support to meet changing
environmental demands (Friedman, Thayer, 1998a, 1998b; Thayer, Friedman, 1997; Thayer,
Friedman, 2004).
Direction of Research
Underscored in all of this is that a flexible environment requires flexibility in the body,
the brain, and the integration of the two. So, how can we better understand how to keep our
brains and our bodies flexible as we age? To answer this question is the work of a vast
interdisciplinary field of research. Key in this work is the theory that multiple variables at diverse
system levels act to induce positive feedback loops with negative consequences for human
health. Thus, parsing apart the interactions between these variables and their relationship to
health outcomes is an imperative field of study. In order to begin to tackle these complex
questions, we must continue to investigate: a) what the relationships are between multilevel
system factors, b) how these factors interact and relate, c) which factors in this system are
- 14 -
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modifiable, d) how this varies across different population characteristics, and e) the effects of all
of this on diverse, longitudinal health outcomes.
Neurovisceral integration suggests that heart rate variability and executive function are
related. However, what moderates this interaction, how this relationship changes depending on
distinct executive functions, and the predictive power of heart rate variability on executive
function decline have all received limited scientific attention. Strikingly, nearly all published
studies examining cognitive function in relation to heart rate variability are cross-sectional by
design. If, in theory, increased rigidity in autonomic systems marks the beginning of hierarchical
system dysregulation resulting in cognitive decline, it is necessary for research to look at the
longitudinal effects of autonomic function on cognition. Moreover, it is imperative that research
investigate executive function components rather than executive function as only a unitary
construct, given the distinguishable contributions of different executive functions to the
executive system overall. Further, exploring how this relationship is modified is an open area for
research which holds promise for cognitive intervention and increased quality of life in an aging
population.
Dissertation Study
The present study aims to better understand the relationship between autonomic nervous
system functions and longitudinal cognitive decline in aging adults. The study particularly
investigates whether HF HRV can be used to predict declines in measures of distinct executive
functions (i.e., shifting, inhibition, and updating). It further examines biological and
psychological moderators of the relationship between HF HRV and executive functions;
including inflammation (Interleukin-6), stress (salivary cortisol), sleep (PSQI), and mood and
anxiety (MASQ-D and MASQ-A).
- 15 -
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This study is important in that it investigates possible predictors of decline in a cognitive
domain essential for daily functioning and quality of life. It is both innovative and novel in that it
utilizes a longitudinal design and examines distinct executive function outcomes. Results from
this study add to the growing literature on the neurovisceral integration theory, deepen our
knowledge regarding how interrelated nervous system processes relate over time, and provide
insight into potential areas for intervention and further research in the field of healthy aging.
Hypotheses
Our hypotheses were as follows:
Based on neurovisceral integration theory, which posits that HF HRV measures a
dynamic regulatory system with direct effects on prefrontal brain networks, we hypothesize that
HF HRV will predict declines in specific executive functions. Specifically, we expect that:
1). Adults with higher HF-HRV at baseline will have a lesser decline in inhibitory executive
function (as measured by latency scores on the SGST) relative to those with lower baseline HFHRV.
2). Adults with higher HF-HRV at baseline will have a lesser decline in shifting executive
function (as measured by latency scores on the Mixed SGST) relative to those with lower
baseline HF-HRV.
3). Adults with higher HF-HRV at baseline will have a lesser decline in updating executive
function (as measured by total trial score on backwards Digit Span) relative to those with lower
baseline HF-HRV.

- 16 -
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Given that known biological, mental, and behavioral health factors are related to both HF
HRV and executive function, we also hypothesize that such factors will modify the predictive
relationship between HF HRV and executive function declines. Specifically, we expect that:
4). There will be an interaction effect between HRV and anxiety such that the predictive power
of lower HRV on decline in each executive function domain will be lower for adults with lower
levels anxiety as assessed by the total score on the Mood and Anxiety Symptom QuestionnaireAnxiety Symptoms.
5). There will be an interaction effect between HRV and depression such that the predictive
power of lower HRV on decline in each executive function domain will be lower for adults with
lower levels depression as assessed by the total score on the Mood and Anxiety Symptom
Questionnaire-Depressive Symptoms.
6). There will be an interaction effect between HRV and sleep such that the predictive power of
lower HRV on decline in each executive function domain will be higher for those with lower
global sleep scores on the Pittsburgh Sleep Quality Index.
7). There will be an interaction effect between HRV and inflammation such that the predictive
power of lower HRV on decline in each executive function domain will be higher for those with
higher inflammation as measured by blood levels of Interleukin-6.
8). There will be an interaction effect between HRV and stress such that the predictive power of
lower HRV on decline in each executive function domain will be higher for those with higher
salivary cortisol.
Method
Sample
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This study used data from the Midlife Development in the United States (MIDUS)
research project. The MIDUS project is a complex longitudinal study involving wide-ranging
data collection across diverse disciplines which began in 1995 and continues to this day. The
project was conceived by a multitude of scholars who were interested in understanding the biopsycho-social processes of aging. The original MIDUS sample (Wave 1) consisted of 7108
participants. Data collected from Wave 1 of the MIDUS study included phone interview and
self-administered questionnaire data. (Brim, Ryff & Kessler, 2004). In Wave 2, 4,963
participants were successfully recruited from the original sample and were administered followup surveys as well as cognitive and biomarker measures. Wave 3 successfully retained 3,294
participants and included follow-up measures of previously administered questionnaires and
cognitive tests. All waves involved extensive data collection occurring over a number of years.
Wave 2 occurred from 2004 to 2006 and Wave 3 occurred from 2013 to 2015. (Radler & Ryff,
2010). (“History & Overview of MIDUS,”). As cognitive data was not available at Wave 1, the
current study only used data from Wave 2 and Wave 3 of MIDUS in assessing change in
cognition. Further, only participants who had valid biomarker data from Wave 2 were included
in the analysis. Thus, a total of 881 participants were included in the current study.
Measures
Cognitive Measures
Executive function was measured using several indices which were administered as part
of a larger neuropsychological assessment battery at both Wave 2 and Wave 3 of the MIDUS
study (Lachman, Agrigoroaei, Tun, &Weaver, 2014). The larger neuropsychological battery
administered was the Brief Test of Adult Cognition developed by Margie Lachman (Lachman,
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2012). Specific executive function subtests measured inhibition, set-shifting, and updating
components of executive function (described in Miyake et al., 2000).
In the current study, dependent measures of executive function decline were calculated as
the difference between Wave 2 and Wave 3 performance scores. Thus, inhibition decline was
measured as each participant’s inhibition score at Wave 2 minus their score at Wave 3 on the
same measure. Shifting decline was measured as each participant’s shifting score at Wave 2
minus their score at Wave 3 on the same measure. Likewise, updating decline was measured as
the difference in performance scores on Wave 2 and Wave 3. However, in the case of updating,
decline was calculated as performance score on Wave 3 minus performance score on Wave 2. In
this way, each dependent measure was expressed as a negative score if decline occurred, with
more negative scores demonstrating higher levels of decline.
Inhibition
Inhibition was measured using the Stop-and-Go Switch Task (SGST; Tun & Lachman,
2006)-Reverse condition. This condition requires participants to respond “STOP” for ‘GREEN’
and ‘GO’ for ‘RED’ for 20 block trials after being tasked with responding the opposite under the
SGST-Normal condition administered prior for 20 blocks. The SGST measures both accuracy
(performance scores) and latency (response time in milliseconds). Change in mean latency scores
were used in the analyses. Range of possible latency scores was 0 to 150 and higher scores were
suggestive of lower inhibitory functioning. Negative difference scores, calculated as mean
inhibition latency scores from Wave 3 subtracted from those at Wave 2, represent a decline in
inhibition performance over time.
Shifting
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Set-shifting was measured by the SGST Mixed-Task Switch block trials (Tun &
Lachman, 2006) which requires participants to switch response styles between normal and
reverse conditions at random times across 32 trials depending on given cues relating the style to
use (‘NORMAL’ or ‘REVERSE’). Data from this measure results in accuracy and latency
indices for analysis of set-shifting. Change in mean latency scores were used in the analyses.
Range of possible latency scores was 0 to 150 and higher scores were suggestive of lower
shifting ability. Negative difference scores, calculated as mean shifting latency scores from
Wave 3 subtracted from those at Wave 2, represent a decline in shifting performance over time.
Updating
Updating was measured using digit span-backward which requires working memory
capacity to hold information in mind while simultaneously manipulating it. Specifically,
participants are required to remember a series of numbers and then asked to repeat them in
backwards order. Change in number of correct trials were used in the analyses. Range of possible
scores was from 0 to 16. Higher scores were suggestive of higher updating function. Negative
difference scores, calculated as updating scores from Wave 2 subtracted from those at Wave 3,
represent a decline in performance over time.
Autonomic Measure
High Frequency Heart Rate Variability
Autonomic function was measured using vagally mediated heart rate variability (vmHRV), also known as high frequency heart rate variability (HF-HRV). HF HRV was measured
using beat-to-beat electrocardiogram waveform analysis over an 11-minute resting baseline
period. Scores for analysis were derived by averaging HF HRV over two 300 second epochs on
the ECG recording. HF HRV was operationalized as the variability in the series of intervals
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between consecutive R waves on electrocardiogram (ECG) recordings (specifically in the high
frequency band). High frequency was defined as between the 0.15-0.40 hertz range. Procedures
for the noise reduction, filtering, and recommended adjustments that were made during the
acquisition and processing of ECG signals can be found in the Lachman (2017) physiology
protocol. Data was analyzed with HF HRV as a natural log-transformed continuous predictor
variable given its known skew. A more detailed overview of the collection of this measure can
be found in Appendix A.
Exploratory Measures
Mood and Anxiety Symptoms Questionnaire
The Mood and Anxiety Symptoms Questionnaire (MASQ) is a self-report questionnaire
made up of 77-items which measure depressive, anxious and mixed symptomatology (Watson et
al., 1995). Within the questionnaire, there are three scales which assess General Distress:
depressive symptoms (12 items), anxious symptoms (11 items) and mixed symptoms (15 items).
Additionally, there is a depression scale (Anhedonic Depression, 22 items) and an anxiety scale
(Anxious Arousal, 17 items). Higher scores reflect higher levels of symptomatology. General
Distress-Depressive scores were used to assess mood as a moderator while General DistressAnxious scores were used to assess anxiety as a moderator. The internal consistency for each
scale is reported as excellent with coefficient alphas that range from 0.78 to 0.92.
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) is a self-report measure that assesses the
subjective pattern and quality of sleep in adults (Buysse et al., 1989). It measures 7 specific
domains of sleep over a one-month period: subjective sleep quality, sleep latency, sleep duration,
habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction.
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Each domain is scored from 0 to 3 with higher scores reflecting more negative sleep outcomes.
There is also a global score which combines the scores from each of domain which ranges from
0 to 21. The PSQI global score was used in the analyses to assess sleep quality as a moderator.
Higher global scores reflect lower sleep quality. The reliability coefficient (Cronbach’s alpha) of
the PSQI is 0.83 and it has reported internal consistency.
Interleukin-6
Interleukin-6 (IL-6) is a proinflammatory cytokine which is key for proper immune
function. The efferent vagus nerve has been shown to indirectly regulate cytokine production and
this neuro-immune communication is deemed the ‘cholinergic anti-inflammatory pathway’
(Johnston & Webster, 2009). Serum IL-6 was measured using high sensitivity enzyme-linked
immunosorbent assay (ELISA). The laboratory intra- and inter- assay coefficients of variance
were in acceptable ranges (<10%). The median IL-6 level was 2.15 pg/ml and the interquartile
range (IQR) was 1.36–3.47 pg/ml. All values were natural log-transformed to account for the
typical positive skew.
Salivary Cortisol
Salivary cortisol measures the short-term accumulation of cortisol in the human body.
Salivary cortisol assays were performed using enzymatic colorimetric assay at the Mayo Medical
Laboratory in Rochester, MN. The reported inter-assay coefficients of variation for salivary
cortisol was 6.1%.
Procedure and Participants
The MIDUS project was reviewed and approved by the Education and Social/Behavioral
Sciences and Health Sciences Institutional Review Board at the University of Wisconsin-
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Madison. The MIDUS sample was collected through random digit dialing of a nationally
representative population. City specific over-sampling was conducted in order for increased
racial and geographic representativeness. Eligibility criteria for the sample included being
between the ages of 25-74, English speaking, non-institutionalized and living within the
coterminous United States.
In Wave 1, participants responded to phone interview questions and a mail-in selfadministered questionnaire. Within these questions, information pertaining to sociodemographic
statistics and detailed health were collected. In Wave 2, participants responded to these surveys
and were additionally administered the cognitive measures over the phone. Additionally, a subset
of Wave 2 participants met with researchers in-person for two days at one of three research sites
across the U.S. and had biomarker assays conducted. In Wave 3, select participants again
responded to survey measures and cognitive measures by phone. The current study analyses
included only those participants who had Wave 2 and Wave 3 cognitive data and Wave 2
biomarker and psychological data available. Analyses performed were hierarchical and
moderated multiple regressions.
Regression Analyses
Our independent variable in our set of regression analyses was heart rate variability at
baseline measured by high frequency heart rate variability. This measure was normalized by
taking the natural logarithm and analyzed as a continuous variable. Using this independent
variable, we conducted separate hierarchical regression analyses on each of the following
continuous dependent measures: inhibitory, shifting, and updating decline as measured by
difference scores on SGST-reverse, SGST-switch, and DS-backwards, respectively. Difference
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scores were calculated as the decline in performance scores on each executive function task from
Wave 2 to Wave 3 of the MIDUS study. In all analyses we controlled for age.
In exploratory analyses, we further tested the hypotheses that global sleep quality (PSQI
global score) and depression (MASQ-D score) modify the predicted relationship between heart
rate variability and inhibition decline. We also tested whether sleep quality, depression, or
anxiety modified the relationship between heart rate variability and shifting decline. We
completed these analyses by running moderated hierarchical regressions for each variable listed.
Results
Of the 7,109 MIDUS participants, 881 had valid biomarker and cognitive data and were
therefore included in the final analyses. Demographics of these participants are included in Table
1. The included participants differed significantly from drop-out participants with regard to age,
education, ethnicity, and baseline cognitive function (i.e., drop-outs were older, less educated,
less white, and scored lower on baseline cognitive measures; See Hughes et al., 2018 for further
details). Scores on all measures decreased from Wave 1 to Wave 2 in the study sample; however,
updating decreased significantly less than inhibition and shifting overall (Figure 1).
Table 1. Sample Characteristics
Characteristic
Age: m (SD) range
Gender: n (%)
Female
Male
Ethnicity: n (%)
White
Non-white
Education: n (%)
Grade school

Overall Sample (n=881)

Mid-life (n=485)

Late Life (n=396)

55.8 (6) 42-65

74.4 (6.4) 66-94

55.1
44.9

55.8
44.2

58
42

94.9
5.1

92.8
7.2

96.3
3.7

<1

<1

<1

64(11) 42-94
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Middle school
Some high school
GED
Some college
College graduate
Some graduate school
Master’s degree
Professional degree
Heart Rate Variability: m (SD)
Inhibition Decline: m (SD)
Shifting Decline: m (SD)
Updating Decline: m (SD)
Salivary cortisol: m (SD)
Interleukin-6: m (SD)
Sleep Quality: m (SD)
Depression (MASQ-D): m (SD)
Anxiety (MASQ-A): m (SD)

1.1
4.2
23.9
29.0
21.9
2.3
12.5
5.2

<1
2.9
20.3
29.4
25.7
1.8
14.2
5.7

1.1
5.9
27.2
29.1
17
3.2
10.8
5.3

4.9 (1.3)
-.31 (.29)
-.36(.59)
-.09(1.57)
12.4 (54.8)
2.22 (0.95)
6.2 (3.8)
18.6 (6.7)
16.7 (7.9)

5.1 (1.3)
-.32 (.29)
-.36 (.51)
.00 (1.5)
12.9 (77)
2.1 (0.94)
6.3 (3.7)
19.5 (7.1)
17.2 (7.1)

5.0 (1.2)
-.30 (.29)
-.36 (.56)
-.14 (1.52)
12.1 (61)
2.29 (0.94)
6.1 (3.9)
17.9 (7.0)
16.2 (8.1)

Figure 1. Declines in Executive Function Measures from Time 1 to Time 2

EF Performance Scores at Times 1 and 2
70

Performance Score

60
50
40
30
20
10
0
Inhibition

Shifting

Type of Executive Function
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Time 1
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Using a hierarchical framework, we conducted linear regression to examine the effects of
heart rate variability on executive function decline over 9 years in mid- and late life adults. Midlife adults were defined as adults ranging in age from 42 to 65 and late life adults were defined as
adults ranging in age from 66 to 94. This cutoff was used based on standard research cutoffs for
mid- and late life adults. Of the 881 total participants, 485 were mid-life and 396 were late life
adults.
Prior to running analyses, scatterplots of each variable relationship were inspected.
Assumptions of normality, linearity, and homoscedasticity were reasonably met. Minimal
outliers were observed and none were excluded from analyses. Heart rate variability was
naturally log transformed to correct for its positively skewed distribution. Variables within
moderated multiple regression analyses were mean centered to minimize multicollinearity.
Bivariate Correlations
We first analyzed bivariate correlations between dependent variables of interest and
demographic variables in order to explore these relationships (Table 2). Age was significantly
negatively correlated with inhibition and updating decline. Education and gender were not
significantly correlated with any of the outcome variables and were not included in any of the
models. Age was entered into block one of the hierarchical regression models predicting
inhibition, shifting, and updating decline.
Table 2. Bivariate Correlations between Outcome Variables and Demographic Variables
Shifting

Updating
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Inhibition Decline

.509**

Shifting Decline

.027

-.069**

-.021

-.014

.030

.010

-.020

.008

.018

-.005

Updating Decline

-.089**

Age

-.153**

Education

.008
-.098**

p<.05*, p<.01**, n=881

We also analyzed the bivariate relationships between outcome variables and our other
variables of interest (Table 3). Correlational analyses demonstrated that decline in inhibition
ability was significantly negatively correlated with HF HRV f (r = -.072, p < .05, two-tailed),
global sleep quality (r = -.114, p < .01, two-tailed), and depression (r = .-.070, p < .05, twotailed). Decline in shifting ability was significantly negatively correlated with global sleep
quality (r = -.129, p < .01, two-tailed), depression (r = -.149, p < .01, two-tailed), and anxiety (r =
-.102, p < .01, two-tailed). Updating ability was not correlated with any of the hypothesized
moderator variables. Interestingly, inflammation and stress were not correlated with decline in
any executive function ability.
However, inflammation was significantly negatively correlated with heart rate variability
(r=-.171, p<.01, two-tailed) and global sleep quality (r=0.82, p<.01, two-tailed). Additionally,
sleep quality was significantly correlated with depression (r=0.411, p<.01, two-tailed) and
anxiety (r-.416, p<.01, two-tailed) scores. Depression and anxiety were also significantly
correlated (r=.712, p<.01, two-tailed), as were inhibition and shifting decline (r=.509, p<.01,
two-tailed). Stress (as measured by salivary cortisol) was not correlated with any other variable.
Table 3. Bivariate Correlations between Variables of Interest
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Variable
Inhibition

1
.509**

1. Shifting
2. Updating
3. HRV

2

3

4

5

6

7

Anxiety

.027

-.072*

-.114**

-.030

.050

-.070*

.030

-.018

-.129**

-.005

.004

-.149** -.102**

.044

-.032

-.002

.018

.031

-.017

.013

-.019

-.171**

.016

-.002

-.009

.082**

.411**

.416

.003

.001

.015

-.013

-.001

4. Sleep Quality
5. Stress
6. Inflammation
7. Depression

-.027

.712**

p<.05*, p<.01**, n=881

Heart Rate Variability as a Predictor of Executive Function Declines
Hierarchical regression was used to identify the significance of heart rate variability in
predicting declines in inhibition, shifting, and updating. Age was entered as a covariate in block
one of each regression model. In each case, this was followed by entering heart rate variability as
a predictor variable. Results of these analyses are shown in Table 4.
In our first hierarchical regression analysis we examine inhibition decline as our outcome
variable. At block one, a significant model emerged [F (1, 870) = 15.828, p < .01, R2=.018],
with age predicting 1.8% of the variance in inhibition change scores. At block two, upon entering
heart rate variability, the model remained significant [F (2, 869) = 8.460, p < .01, R2=.019] and
explained 1.9% of the variance in inhibition change scores. However, the change in R square
(R2= .001) was not statistically significant [F (2, 869) = 1.090, p = .297]. This suggests that heart
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rate variability was not a significant predictor of change in inhibition decline above and beyond
age (Table 1, Figure 2).
Another regression was calculated to examine the role of heart rate variability in
predicting decline in the cognitive ability of shifting. At block one, a significant model emerged
[F (1, 859) = 4.899, p < .05, R2=.006], with age predicting 0.6% of the variance in inhibition
change scores. At block two, upon entering heart rate variability, the model no longer remained
significant [F (2, 858) = 2.451, p = .087, R2=.006], continuing to explain only 0.6% of the
variance in inhibition change scores. This suggests that heart rate variability was not a significant
predictor of change in inhibition decline above and beyond age (Table 2, Figure 3).
A final hierarchical regression was calculated to examine the role of heart rate variability
in predicting longitudinal change in the cognitive ability of updating. At block one, age was
entered, creating a significant model [F (1, 905) = 4.532, p < .05, R2=.005] which explained
0.5% of the variance in updating change scores. At block two, heart rate variability was entered,
creating a model [F (2, 904) = 2.549, p= .079, R2=.006] which explained 0.6% of the variance in
updating change scores. The change in R square (R2= .001) was not statistically significant [F (2,
904) = 0.568, p = .451, R2=.007]. This suggests heart rate variability was not a significant
predictor of updating decline above and beyond age (Table 3, Figure 4).
Table 1. Regression Analyses of HRV as a Predictor of Executive Function Declines
Analysis #1: Inhibition Decline
Predictor

Age

Block 1

Block 2

b (SE) B

b (SE)B

.004 (.001).134**

.003 (.001) .123**
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HRV

-.008 (.008) -.037

.138 (.001)

p<.05*, p<.01**

Figure 2. Regression Scatterplot of HF HRV on Inhibition Decline, Controlling for Age

HF HRV

Analysis #2: Shifting Decline
Predictor

Age
HRV

Block 1

Block 2

R (R2)

b (SE) B

b (SE) B

.003 (.002) .075*

.003 (.002) .076*

.075 (.006*)

.001 (.013) .003

.075 (.000)

p<.05*, p<.01**

Figure 3. Regression Scatterplot of HF HRV on Shifting Decline, Controlling for Age
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HF HRV

Analysis #3: Updating Decline
Predictor

Age
HRV

Block 1

Block 2

b (SE) B

b (SE)B

-.10 (.005) -.071*

R (R2)

-.009 (.005) -.063 †

.071 (.005*)

0.31 (.041) .026

.075 (.001)

p<.10 †, p<.05*, p<.01**

Figure 4. Regression Scatterplot of HF HRV on Updating Decline, Controlling for Age
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HF HRV

Moderators of Heart Rate Variability and Executive Function Declines
In order to test the impact of hypothesized moderators on the relationship between heart
rate variability and executive function declines, specific moderated multiple regressions were
analyzed. Sleep quality and depression were examined as moderators of heart rate variability and
inhibition decline. Sleep quality, depression, and anxiety were examined as moderators of
shifting decline. No moderator analyses were run with updating decline as an outcome variable.
In the regression analyses investigating inhibition decline as the outcome variable, age
was entered at block one. In block two, heart rate variability was entered along with either sleep
quality or depression. At block three, an interaction term between each either sleep quality or
depression and heart rate variability was entered in order to test the significance of each as a
moderator. In analyses with shifting as the outcome variable, heart rate variability and either
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sleep quality, depression, or anxiety were entered at block one. In block two an interaction term
between either sleep quality, depression, or anxiety was entered.
Results demonstrated a significant interaction effect between depression and heart rate
variability in regressions on both inhibition (t=2.527 (3, 870), p=.012) and shifting decline
(t=2.072 (3, 870), p=.039). Sleep quality did not significantly interact with heart rate variability
and either inhibition or shifting decline. However, significant main effects of sleep quality on
both inhibition (t=-2.582, (3, 870) p<.01) and shifting (t=-2.775, (3, 870) p=.01) decline were
demonstrated. Likewise, while anxiety did not interact with heart rate variability in the
regression on shifting decline, there was a significant main effect of anxiety on shifting decline
(t=-2.681, (3, 870) p<.01). Results of these analyses are shown in Table 5.
Table 5. Moderated Multiple Regression Analyses of HRV and Executive Function Declines

Analysis #1: Depression and Inhibition Decline
Block 1

Block 2

Block 3

Variable

(SE) B

(SE) B

(SE) B

Age

(.001) .132**

(.001) .113**

(.001) .108**

.132 (.017**)

HRV (centered)

(.008) -.035

(008) -.038

.145 (.004)

Depression (centered)

(.002) -.050

(.002) -.058 †

HRV X Depression (centered)

(.001) .085*

p<.10 †, p<.05*, p<.01**
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Analysis #2: Depression and Shifting Decline
Block 1

Block 2

Block 3

Variables

(SE) B

(SE) B

(SE) B

Age

(.002) .076*

(.002) .055

(.002) .050

.076 (.006*)

HRV (centered)

(.013) .006

(.013) .005

.151 (.017**)

Depression (centered)

(.003) -.132**

(.003) -.137**

HRV X depression (centered)

(.002) -.070*

R (R2)

.166 (.005*)

p<.05*, p<.01**

Analysis #3: Sleep Quality and Inhibition Decline
Block 1
Block 2
Block 3
Variable

(SE) B

Age

(.001) .130**

(SE)B

R (R2)

(SE) B

(.001) .113**

(.001) .112**

.130 (.017*)

HRV (centered)

(.008) -.036

(.008) -.036

.162 (.009*)

Sleep Quality (centered)

(.003) -.089**

(.003)-.089**

HRV X Sleep Quality (centered)

(.002) .021

p<.05*, p<.01**
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Figure 5. Main Effect of Sleep Quality on Inhibition Decline, Controlling for Age

Sleep Quality

Analysis #4: Sleep Quality and Shifting Decline
Block 2
(SE)B
(.002) .063 †

Block 3
(SE)B
(.002) .063 †

R (R2)

HRV (centered)

(.013) .001

(.013) .001

.119 (.009*)

Sleep Quality (centered)

(.005) -.097*

(.005) -.097*

Variable
Age

Block 1
(SE) B
(.001) .069*

HRV X Sleep Quality (centered)

(.004) .006

p<.10 †, p<.05*, p<.01**
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Figure 6. Main Effect of Sleep Quality on Shifting Decline, Controlling for Age

Sleep Quality

Analysis #5: Anxiety and Shifting Decline
Block 1

Block 2

Block 3

Variables

(SE) B

(SE) B

(SE) B

Age

(.002) .076*

(.002) .065†

(.002) .066†

.076 (.006*)

HRV (centered)

(.013) .002

(.013) .002

.118 (.008*)

Anxiety (centered)

(.003) -.091**

(.004) -.092**

HRV X Anxiety (centered)

(.002) -.015

p<.10 †, p<.05*, p<.01**

- 36 -

R (R2)

.119 (.000)

Running head: BIOBEHAVIORAL PREDICTORS OF EXECUTIVE FUNCTION DECLINE
Results by Age Group
The sample population included 485 mid-life adults (44-65 years old) and 396 late life
adults (66-92 years old). In order to compare the study results between mid- and late life adults,
sub-analyses were run to examine how age group affected each regression (Table 6). It was
demonstrated that age significantly predicted decline in inhibition and updating in late life adults.
In contrast, age was not a predictor of decline in any executive function domain in mid-life
adults. Further, depression moderated the relationship between inhibition and HRV and shifting
and HRV only in mid-life adults. Sleep quality and anxiety predicted declines in shifting and
inhibition only in late-life adults.
Table 6. Results Compared by Age Group
Result

Mid-life Adults (42-65)

Late Life Adults (66-94)

(SE) B
(.002) -.032

(SE) B
(.002) -.125*

Age as a predictor of
shifting decline

(.003) .009

(.004) .060

Age as a predictor of
updating decline

(.11) -.058

(.012) -.107*

Depression as a moderator of
HRV and inhibition decline

(.005) .139**

(.002) -.035

Depression as a moderator of
HRV and shifting decline

(.002) .092*

(.004) -.032

Anxiety as a predictor of
shifting decline

(.004) -.031

(.006) -.208**

Sleep quality as a predictor of
inhibition decline

(.004) -.075 †

(.004) -.154**

Sleep quality as a predictor of

(.006)-.047

(.008) -.190**

Age as a predictor of
inhibition decline
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shifting decline
p<.1 †, p<.05*, p<.01**

Discussion
Study results demonstrated that an index of resting high frequency heart rate variability
exhibited a correlation with longitudinal decline in executive function. However, it was only
significantly correlated with decline in inhibitory executive function. Additionally, it was not
predictive of decline in inhibition above and beyond known demographic variables (i.e., age).
These results are counter to our hypotheses in that heart rate variability did not
independently predict decline in inhibition, shifting, and updating over time. However, the
correlation between HF heart rate variability and inhibition decline does partially align with
previous observations which demonstrate a correlational relationship between HF HRV and
inhibition ability (Albinet, Abou-Dest, André, & Audiffren, 2016; de Oliveira Matos, Vido,
Garcia, Lopes, & Pereira, 2020; Stenfors, Hanson, Theorell, & Osika, 2016; Zeki Al Hazzouri,
Elfassy, Carnethon, Lloyd-Jones, & Yaffe, K, 2017). Our results suggest that while HF HRV and
executive function are generally correlated, HF HRV may not be a predictor of decline in
executive function over time. This is important for considering whether HF HRV is a relevant
biomarker of healthy aging and suggests it may serve as a marker of an individual’s current
cognitive function but not a marker of later cognitive decline.
That said, it will be interesting for future research to examine whether changes in HF
HRV are predictive of changes in cognitive decline. It is possible the pattern of change between
HF HRV and cognitive variables is more clinically relevant than the relationship between
baseline HF HRV and change in cognition. It is also imperative to note that HF HRV is only one
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measure of heart rate variability. Inasmuch, future research should examine whether different
measures of HF HRV may predict executive function decline. Future research should also
investigate whether HF HRV is correlated with raw executive function scores at Wave 1 and
Wave 2 within the MIDUS study in order to more clearly understand its correlational versus its
predictive relationship to executive function.
Our results also demonstrate the importance of including age as a covariate when
analyzing the relationship between heart rate variability and inhibition function in older adults.
As Britton et al. (2018) reported earlier, many published studies investigating the relationship
between heart rate variability and cognition do not include appropriate covariates (i.e., age)
which may vastly skew results presented in the literature. This is a critique of our own study as
well—as it will be important to examine our own results with the inclusion of further relevant
covariates. Of course, knowing which covariates are most relevant to each cognitive domain and
age group requires additional study.
Study results did support a significant interaction effect between depression and HF HRV
on inhibition and shifting function declines. These results suggest that depression combined with
HF HRV did a better job of predicting both declines than either variable alone. Clinically, this
may indicate that depression moderates the long-term impact of HF HRV on executive function.
Of note, when the results were investigated on the basis of mid-life (42-65 years of age) versus
late life (66-94 years of age) adults, it was found that depression specifically moderated the
relationship between heart rate variability and executive function declines in mid- but not late
life adults.
In discussing these results, it is important to highlight differences in findings across
executive function domains. Ostensibly, while the relationships between HF HRV and inhibition
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and shifting declines are modified by depression, the relationship between HF HRV and updating
decline is not. An explanation for these results may relate to neurological network structures.
Intriguingly, depression is thought to represent dysregulation of frontal cortical networks (Li,
Friston, Mody, & Wang, 2018). Similarly, evidence suggests inhibition and shifting abilities are
primarily frontally mediated. In contrast, updating relies heavily on working memory and may be
regulated by more distributed networks within both the frontal and temporal lobes (Alvarez &
Emory, 2006). If such is the case, low HF HRV—which has been shown to correlate with
decreased frontal lobe activity—in a depressed individual, may exacerbate dysregulation of
frontal networks (Wei, Chen, & Wu, 2018). This could result in a demonstrably compromised
ability to engage in cognitively demanding tasks requiring specific frontal network involvement.
In contrast, cognitive tasks such as updating, which are more broadly distributed in neurological
networks, may be less impacted by both HF HRV and depression.
Altogether, this emphasizes the need to consider cognitive tasks in regards to both the
functions they confer as well as the neurological structures integral to their execution. Inasmuch,
our results support previous research demonstrating that executive function tasks are distinctive
in the functions and structures they measure. Thus, executive functions should be investigated as
distinct constructs (Miyake et. al, 2000).
Clinically, the result that depression and HF HRV together predict inhibition and shifting
declines makes good sense. In depression, the ability to inhibit negative thoughts and shift
thinking and behavior patterns is impaired. Thus, it is not surprising that depression predicts
inhibition and shifting function. In addition, HF HRV is analogous to inhibiting and shifting
physical energy, enabling us to engage with cognitive tasks at appropriate levels of effort and
intensity. The combination of depression and low HF HRV may result in restricted inhibition and
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shifting abilities combined with limited energy to engage in such tasks. In contrast, the
combination of depression and high HF HRV may result in restricted inhibition and shifting
abilities albeit sufficient energy to engage in cognitive performance tasks.
While this interpretation is not perfect, it does highlight how effective integration across
mental and physical domains is important for long-term health outcomes. This is not surprising
at a commonsense level—physical and mental processes bidirectionally influence one another;
for example, when people feel depressed they tend to exercise less and when they exercise less
they tend to feel more depressed. What is intriguing is the result that depression and HF HRV
combined are not only correlated with cognitive performance but are predictive of declines in
cognitive performance over a nine-year period. In accordance with neurovisceral integration
theory, these physical and mental markers of dysregulation may be early signs of an underlying
process which builds further dysregulation across systems over time.
Overall, moderation results underscore the importance of psychological functioning in
mid-life for healthy aging over time. Given that the data suggests depression moderates the
relationship between physiological functioning and longitudinal cognitive abilities, clinical
interventions for mood in mid-life could have long-term benefits for physical, mental, and
cognitive health. Previous research suggests that differences in heart rate variability in depressed
individuals may confer greater health risks with regards to physical disease (Van der Kooy et. al,
2006). The current study expands on these findings by supporting that differences in heart rate
variability in depressed individuals may confer greater risk of certain neuropsychological
declines as well.
Given that there are effective interventions for depression, our results highlight the need
to take such intervention seriously. In studies by Hartmann, Schmidt, Sander, & Hegerl (2019)
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and Economides et. al (2020), cognitive behavioral therapy, behavioral activation, and
antidepressant medication were shown to improve both depression and heart rate variability in
mid-life adults. Such research offers hope that similar interventions may lessen specific cognitive
declines in addition to improving mental and physical health.
Interestingly, prior research demonstrates that depression is a highly heterogenous
disease; and not all depression presents with overt physiological symptoms (Hasler, 2010).
However, depression severity is related to changes in physiology, including changes in heart rate
variability (Hartmann et. al, 2019). Thus, lower HF HRV may serve as a marker of a more severe
depression. In accordance with current study results, it may be that depressed individuals who
have marked physiological symptoms of depression may be at greater risk of specific cognitive
decline. Previous research has suggested that HRV may serve as a biomarker of depression
severity and subtypes (Hartmann et al., 2019). Our results additionally suggest that depression, in
combination with HF HRV, may serve as a helpful marker of later cognitive decline.
Due to the relevance of HRV to depression, physiological intervention may be an
exciting way to enhance clinical improvement in depressed individuals. Recent intervention trials
are promising in this regard. Indeed, research in the elderly showed that an 8-week HRV
biofeedback program improved HRV and depression (Zaccaro, 2018). Further, a study by Lin et.
al (2019) demonstrated that heart rate variability biofeedback improved HRV indices and
depression symptoms in adults aged 20 to 75. Given current results, future research should
investigate whether HRV biofeedback can lessen executive function declines as well.
Of note, our result showing that depression and HF HRV moderate executive function
decline in mid- but not late-life adults is important to consider. It is possible that dynamic
factors, such as depression and HF HRV, are more relevant to health in middle age whereas
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static factors carry more weight in older adults. This is further supported by our result that age
was only predictive of cognitive decline in late life adults. Alternatively, HF HRV may simply
have too restricted a range in older adults to impact the relationship between depression and
cognitive decline. However, while HF HRV range has been shown to be more limited in older
versus younger adults in previous studies, our study did not demonstrate a range difference in HF
HRV between mid- and late life adults (Phyllis et. al, 2009).
Interestingly, results from the current study also demonstrated that sleep quality was a
significant predictor of executive function declines in inhibition and shifting above and beyond
age. In addition, anxiety was a significant predictor of shifting decline above and beyond age.
However, these effects were only significant for late life rather than mid-life adults. These results
underscore the importance of additional emotional and behavioral health factors in healthy aging.
Importantly, sleep quality is suggested to be a modifiable lifestyle factor (Dalmeses et. al, 2019).
Research supports that non-pharmacological interventions such as sleep hygiene, sleep
education, phototherapy, stimulus control, relaxation, cognitive behavioral therapy, and exercise
can significantly improve sleep quality ratings across age ranges (dos Santos et. al, 2018;
Murawaski et al., 2017). Many effective treatments exist for anxiety as well, including diverse
psychotherapies and anxiolytic medications (Nutt, 2005).
Of note, investigations into whether stress or inflammation moderated heart rate
variability and executive function decline suggested neither were significant moderators. These
results were counter to our hypotheses. Such results are intriguing given that biological factors,
like cortisol and interleukin-6, are typically considered better biomarkers of disease than mental
or behavioral health factors (Thompson & Voss, 2009). However, our results suggest that selfreported depression, anxiety, and sleep quality are all predictors of cognitive health over time
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whereas these common biological measures are not. This result highlights the importance of
considering mental and behavioral health, in addition to physical health, when researching
healthy and diseased aging. It also gives additional credit to the notion of using mental and
behavioral factors as biomarkers for health and wellness.
Overall, the results of our study show that specific modifiable factors affect executive
function decline. Given the strong relationship between executive function and quality life, it is
likely these factors also impact quality of life in both mid- and late life adults. Future research on
when and how to change these processes in the course of aging is recommended in order to
expand our knowledge of aging well.
Limitations
The current study is noted to have a number of limitations. Particularly, the study used
difference scores to determine longitudinal decline. While this demonstrates decline it does so
with only two measures rather than with three or more measures over a period of time,
conferring less statistical power for observing longitudinal effects. However, measuring
cognition with the same measure more than twice during the nine-year study period may have
led to practice effects, limiting clinical validity of the observed declines. Thus, the current study
utilized a tradeoff between limiting practice effects and limiting the number of test
administrations over the course of the study.
In addition, HF HRV was measured at Wave 2 while cognition was measured as a change
in performance scores between Waves 2 and 3. While HF HRV is known to change over time,
the study did not provide information as to whether or how the Wave 2 HF HRV measure related
to HF HRV over the course of the nine-year study period. Given that HF HRV changes moment
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to moment, our HF HRV measure—which measured resting HF HRV at only one time point
over a ten-minute period—may not have been a sufficiently sensitive measure of participant’s
average baseline parasympathetic tone. It is possible that future studies investigating longitudinal
changes in HF HRV in relation to longitudinal changes in cognition may provide more accurate
insight into how HF HRV and cognition relate to one another over time. In addition, future
studies may want to utilize long-term HF HRV recordings rather than short-term, if looking to
use HF HRV as a predictor of longitudinal declines.
A further limitation is in regards to the measure of updating used in our study. While the
lack of predictive capacity of heart rate variability in predicting updating decline may accurately
represent the resilience of this function to physiological variation, other conclusions should be
considered. Particularly, in descriptive analyses, decline in inhibition and shifting occurred in all
age groups. However, significant decline in updating only occurred in participants 70 and older.
The limited decline in updating ability may have contributed to the non-significant findings
observed in the current study. Further, it is possible that the executive function measures used in
the study were different in their levels of sensitivity towards capturing specified executive
domains. Future studies may want to examine how heart rate variability relates to updating
decline in a sample of old-old adults (75 years and older) or a sample of individuals specifically
observed to have significant decline in updating over time. Additionally, investigations into test
sensitivity may help clarify how much this contributes to current study results.
Another potential limitation of the study is the large age range of the participants
sampled. While we ran sub-analyses to examine how our results differed between mid-life (4265) and older adults (66-94), it is possible that more fine-grained differences exist. For instance,
the relationship between heart rate variability and executive functions for those in their 40s may
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be very different from the same relationship in people in their early 60s. Future research should
examine these relationships across each decade to provide greater insight into whether and how
age modifies these results.
In considering the effects of depression, anxiety and sleep quality on inhibition and
shifting decline, it is imperative to mention that these measures were derived from latency
scores. Inasmuch, processing speed, in addition to executive function, was likely fundamental to
performance. This may skew the interpretation of the results. Future studies should examine how
these variables affect measures of processing speed in addition to executive function, as well as
examine how these variables affect measures of executive function less reliant on processing
speed.
We would also like to note the difference between participants who remained in the study
for Wave 3 and those who dropped out after Wave 2. Demographically, drop out participants
were less educated, less white, older, and had lower baseline cognitive performance scores than
those who remained in the study. Thus, it is cautioned that the study sample is not a true
representation of all mid and late life adults in the United States. In fact, these study participants
represent a healthier version of aging than is typical of the average American. It is therefore
important that future studies examine this study’s effects in less healthy aging individuals.
Additionally, while over-sampling of demographically under-represented populations was
employed in recruiting study participants, the sample used in the current analyses was
predominantly white. As previous research has demonstrated differences in the relationship
between heart rate variability and executive function in African Americans versus whites, it is
important that future research investigate how current results may vary according to race and
ethnicity.
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A more thorough investigation of confounds in the relationship between heart rate
variability, depression, and executive functions may also be warranted. For example, future
studies are recommended to examine how cardiovascular disease, diabetes, exercise, and
medication use may modify the demonstrated results. While a subjective measure of health was
supplementarily examined and found to be unrelated to variables of interest, more specific
measures of health are likely to add extensively to the clinical relevance and nuance of the
current results.
Finally, while our results demonstrated significant findings, it is essential to note that all
of our effect sizes were small. Given our large sample size, such significant statistical findings
should be interpreted with caution. Certainly, future research investigating the true clinical
relevance of these statistical findings is warranted.
Conclusions
All in all, the current study shows that resting high frequency heart rate variability is not
a standalone predictor of decline in specific executive functions. However, HF HRV does
significantly moderate the relationship between depression and longitudinal executive function
decline in inhibition and shifting. Additionally, findings from this study suggest that anxiety
significantly predicts declines in shifting decline and that sleep quality significantly predicts
declines in inhibition and shifting above and beyond age.
These results add substantially to the research literature on heart rate variability and
cognitive decline. Moreover, the results cast light on prevention and intervention targets for
healthy aging. Such targets specifically include depression, anxiety, heart rate variability, and
sleep quality in mid- and late life adults. Results show that each of these factors may directly or
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indirectly lead to increased decline in executive functions of inhibition and shifting.
Imperatively, declines in these functions are related to decreased quality of life in aging adults.
Thus, through tackling identified predictors and moderators of cognitive decline, hope exists not
only for improving physical, mental, and behavioral symptoms—but for increasing overall
quality of life.
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Appendix A: Detailed Psychophysiology Protocol Description
I. Introduction
The MIDUS Biomarker Project (P4) psychophysiology session is a standard, laboratory based
stress reactivity protocol. Our study utilized only the resting baseline portion of the protocol to
obtain our measure of heart rate variability; however, the entire procedure is described below.
The data were collected at UCLA, Georgetown, and the University of Wisconsin and processed
at the Columbia University Medical Center (CUMC) in the laboratory of Dr. Richard Sloan.
This section provides additional information about the protocol and variables included in the
data file organized as follows: Overview of the protocol; description of the measures;
detailed outline of the protocol and data processing; description of variables included in the
data file, particularly the primary outcomes of interest (heart rate (HR), heart rate variability
(HRV), and salivary cortisol); and naming conventions.
II. Overview of Protocol
A. Purpose.
The psychophysiology protocol in Project 4 is a widely used laboratory
based, experimental procedure designed to measure cardiovascular reactivity to and
recovery from stress.
B. Procedure.
During the protocol, participants’ physiological outcomes are measured
during a seated, resting baseline period followed by two cognitive/psychological
stressor tasks, also in a seated position. The cognitive tasks are a mental arithmetic
task (PASAT or MATH) and a Stroop color–word matching task. After each cognitive
stress task, participants undergo another seated, resting period to assess
physiological recovery to stress. The last period in the procedure is an orthostatic
stressor. Participants move from a seated to standing position and remain standing
for several minutes.
C. Physiological outcomes.
Cardiovascular reactivity is assessed via continuous
measurement of the electrocardiogram (ECG). The beat-to-beat ECG waveforms are
then analyzed to calculate heart rate and several indices of heart rate variability
(HRV). Heart rate variability is operationalized as variability in the series of intervals
between consecutive R waves (the first upward deflection of the electrocardiogram
following the Q-wave, arising from ventricular depolarization).
D. Theory and method.
Throughout this guide, relevant references are cited to provide investigators information about
the methodology used in this protocol. We offer the following references,
including one in press paper using Project 4 data, for an introduction and review of cardiac
psychophysiology, and the types of questions that can be investigated with this
type of protocol (Carney, Freedland, & Veith, 2005; Gorman & Sloan, 2000; Shcheslavskaya,
Burg et al., in press (2009); Sloan, McCreath et al., 2007). A recent special issue of Biological
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Psychology (Allen & Chambers, 2007) on cardiac vagal control is a good resource. Investigators
are encouraged to review the literature in more depth.
III. Measures
A. Physiological Measures
1. Acquisition and Processing of ECG Signals. Beat-to-beat analog ECG signals were collected
then digitized at a sampling rate of 500 Hz by a 16-bit National Instruments analog-to-digital
(A/D) board installed in a microcomputer. ECG waveforms were submitted to proprietary event
detection software to identify R waves. Following established procedures, (Berntson, Quigley,
Lang, & Boysen, 1990; Dykes, Ahmann et al., 1986), research staff visually reviewed all ECG
waveforms to correct interactively any software errors in identifying normal R waves. The
resulting series of normal RR intervals was used to calculate the cardiac variables heart rate (HR)
and several standard indices of HRV.
2. Heart rate variability. Time domain indices of RR interval variability include the standard
deviation of RR intervals (SDRR) and the root mean squared successive differences (rMSSD).
Frequency domain measures include spectral power in the low (0.04-0.15 Hz (LF-HRV)) and
high (0.15-0.50 Hz (HF-HRV)) frequency bands. The spectra of RR interval series were
calculated using an interval method for computing Fourier transforms similar to that described
by DeBoer, et al. (DeBoer, Karemaker, & Strackee, 1984). Prior to computing Fourier
transforms, the mean of the RR interval series is subtracted from each value in the series and the
series then is filtered using a Hanning window (Harris, 1978) and the power, i.e., variance (in
msec2), over the LF and HF bands is summed. Estimates of spectral power are adjusted to
account for attenuation produced by this filter (Harris, 1978).
IV. Psychophysiology Protocol Description
The following is a detailed description of the data collection protocol, including equipment
setup, protocol order, and data processing.
A. Protocol Flowsheet:
MIDUS staff who conducted this protocol used a data collection form called the
psychophysiology flowsheet. A copy of this form is in Section B. The first two pages included
questions about handedness, physical characteristics of the participant, and other factors that may
influence experimental outcomes (e.g. consumption of caffeine, nicotine etc.), as well as a
template of the protocol order. A more detailed version of this template appears in Table 1
below. The remainder of the flowsheet contains a more complete description of the protocol,
instructions to research staff, instructions to participants, descriptions of the stress tasks, etc.
Throughout the protocol, staff were instructed to record information at designated locations on
flowsheet. This information as well as responses to the items at the beginning of the flowsheet
were data-entered and included in the MIDUS 2 Project 4 data file.
B. Monitoring Device Setup.
Electrocardiograph (ECG) electrodes were placed on the left and right shoulders, and in the left
lower quadrant. Stretch bands were placed around the participant’s chest and abdomen to
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measure respiration. A Finometer blood pressure cuff was placed on the middle finger of the
non-dominant hand, and a Finometer blood pressure arm cuff was placed on the upper arm on
the same side as the finger cuff. The participant was then seated and a numeric keypad, for
responding to the stress tasks, was secured in a comfortable position relative to the dominant
hand. The monitoring devices were then calibrated in the seated position.
C. Protocol Order.
The general protocol order was as follows (details are in Table 1): seated baseline (11 minutes);
psychological stress task 1 (mental arithmetic or Stroop task – 6 minutes); recovery 1 (6
minutes); psychological stress task 2 (mental arithmetic or Stroop task - 6 minutes); recovery 2
(6 minutes); orthostatic stressor (standing/upright) (6 minutes). No recovery data were collected
after exposure to the orthostatic stressor. Participants were instructed to remain silent throughout
the procedures. After the second recovery period, participants were assisted in moving to a
standing position. The monitoring devices were recalibrated, then the orthostatic stress period
began. The seated baseline recordings were used to produce the HF HRV measure used in our
study.
V. Data Processing Criteria
The physiological monitoring equipment (ECG, Finometer, Inductotrace respirometer) ran
continuously throughout the protocol and produced raw waveform data. These raw data were
processed according to standardized algorithms (Task Force, 1996) to create variables (see Key
Variables) that can be used in analyses. Analytic data are provided in MIDUS by period and by
epoch within each period. The MIDUS 2 Biomarker (P4) data includes one set of data from the
psychophysiology session, which uses 300 second epochs of data. This section defines these
terms and describes the criteria used to select raw physiological waveform data for processing to
generate key variables.
B. Data Epochs for Analysis
Within each protocol period, data were analyzed in specified epochs of time, based
on different criteria and different types of research questions.
C. Epoch Duration and Number of Epochs per Period
1. 300 sec epoch data set:
a. First, data were analyzed with a specified 300 sec epoch duration.
b. The analysis software was programmed such that, if unscorable data
precluded a full 300 sec segment of analyzable data, epoch duration
was decreased by 60 sec segments until a continuous data epoch
could be analyzed.
c. The minimum epoch length provided in this data set is 180 sec;
epochs shorter than that were omitted from this data set. For all
variables except the Low Frequency RRV variables, reasonable
estimates can be obtained from epochs as short as 180 sec.
d. For the 11 min baseline period, we attempt to provide 2 epochs of 300
sec each. Cases with unscorable intervals of data (due to noisy
signal) include 1 or 2 epochs of 300, 240 and/or 180 sec.
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VI. Key Variables and Naming Conventions
A. Key Variables.
The key cardiac variables from the psychophysiology session used by CUMC investigators are
listed below. These output variables are somewhat standardized based on conventions for
measuring heart rate and heart rate variability parameters:
HR: Average heart rate, beats per minute units
SDRR: Standard deviation of RR intervals, msec units
rMSSD: Root mean squared successive differences, msec units
LF_HRV: Low frequency RR interval variability, bandwidth 0.04-0.15 Hz, msec2 units
HF-HRV: High frequency RR interval variability, bandwidth 0.15-0.40 Hz, msec2 units
The data file includes both original and log transformed versions of all HRV variables (the last 4
variables listed above) for each period, and each epoch within a given period, along with
variables indicating Epoch Duration (secs) and the Number of R-R intervals analyzed in each
epoch.
Note: the CUMC team always uses log-transformed versions of the variables (natural
logarithm), a standard practice in HRV research, due to reliable skew in their distributions.
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